History of Extensive Disease Small Cell Lung Cancer Treatment: Time to Raise the Bar? A Review of the Literature

SIMPLE SUMMARY: Small cell lung cancer (SCLC) remains the most aggressive form of neuroendocrine tumor of the lung, for which treatment options remain limited. The introduction of immune checkpoint inhibitors has modified for the first time the therapeutic strategies in patients with extensive disea...

Descripción completa

Detalles Bibliográficos
Autores principales: Lazzari, Chiara, Mirabile, Aurora, Bulotta, Alessandra, Viganó, Maria Grazia, Ogliari, Francesca Rita, Ippati, Stefania, Dell’Oca, Italo, Santarpia, Mariacarmela, Lorusso, Vincenza, Reck, Martin, Gregorc, Vanesa
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7957518/
https://www.ncbi.nlm.nih.gov/pubmed/33673630
http://dx.doi.org/10.3390/cancers13050998

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7957518/
https://www.ncbi.nlm.nih.gov/pubmed/33673630
http://dx.doi.org/10.3390/cancers13050998

Ejemplares similares